Literature DB >> 12417329

Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity.

Jian Hua Wang1, Hui Ling Nie, Siu Cheung Tam, Hai Huang, Yong Tang Zheng.   

Abstract

Trichosanthin (TCS) is a type I ribosome inactivating (RI) protein possessing anti-tumor and antiviral activity, including human immunodeficiency virus (HIV). The mechanism of these actions is not entirely clear, but is generally attributed to its RI property. In order to study the relationship between the anti-HIV-1 activity of TCS and its RI activity, three TCS mutants with different RI activities were constructed by using site-directed mutagenesis. The anti-HIV-1 activities of the three mutants were tested in vitro. Results showed that two TCS mutants, namely TCS(M(120-123)), TCS(E160A/E189A), with the greatest decrease in RI activity, lost almost all of the anti-HIV activity and cytopathic effect. Another mutant TCS(R122G), which exhibited a 160-fold decrease in RI activity, retained some anti-HIV activity. The results from this study suggested that RI activity of TCS may have significant contribution to its anti-HIV-1 property.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417329     DOI: 10.1016/s0014-5793(02)03539-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Ribosome inactivating proteins from plants inhibiting viruses.

Authors:  Inderdeep Kaur; R C Gupta; Munish Puri
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

2.  Effect of extracts of trichosanthes root tubers on HepA-H cells and HeLa cells.

Authors:  Chang-Ming Dou; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

3.  HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA.

Authors:  Xiao-Xin Ren; Hai-Bo Wang; Chuan Li; Jin-Feng Jiang; Si-Dong Xiong; Xia Jin; Li Wu; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

Review 4.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

5.  Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats.

Authors:  Wen-Long Zhao; Du Feng; Ju Wu; Sen-Fang Sui
Journal:  Mol Biol Rep       Date:  2009-08-11       Impact factor: 2.316

Review 6.  Toxic proteins application in cancer therapy.

Authors:  Zahra Setayesh-Mehr; Mahdiye Poorsargol
Journal:  Mol Biol Rep       Date:  2021-04-25       Impact factor: 2.316

7.  The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- κ B Pathway in Mice.

Authors:  Lijuan Chen; Xin Yan; Qianlin Yan; Jiajun Fan; Hai Huang; Xunlong Shi; Lei Han; Tianxiong Han; Haiyan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

8.  Draft genome sequence of bitter gourd (Momordica charantia), a vegetable and medicinal plant in tropical and subtropical regions.

Authors:  Naoya Urasaki; Hiroki Takagi; Satoshi Natsume; Aiko Uemura; Naoki Taniai; Norimichi Miyagi; Mai Fukushima; Shouta Suzuki; Kazuhiko Tarora; Moritoshi Tamaki; Moriaki Sakamoto; Ryohei Terauchi; Hideo Matsumura
Journal:  DNA Res       Date:  2017-02-01       Impact factor: 4.458

9.  X-ray sequence and crystal structure of luffaculin 1, a novel type 1 ribosome-inactivating protein.

Authors:  Xiaomin Hou; Minghuang Chen; Liqing Chen; Edward J Meehan; Jieming Xie; Mingdong Huang
Journal:  BMC Struct Biol       Date:  2007-04-30

10.  Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina.

Authors:  Inderdeep Kaur; Munish Puri; Zahra Ahmed; Fabien P Blanchet; Bastien Mangeat; Vincent Piguet
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.